In Brief This Week: GlaxoSmithKline, EMBL-EBI; Geneva Bioinformatics; Ion Torrent Systems; Bruker; Dotmatics, Almirall | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GlaxoSmithKline has teamed with the European Bioinformatics Institute (EMBL-EBI), the US National Library of Medicine, and informatics provider Collaborative Drug Discovery to freely share the chemical structures of 13,500 molecules from GSK's compound library for malaria research. EMBL-EBI will serve as the primary repository for the data on the compound set.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.